These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17038538)

  • 1. Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.
    Caldas H; Fangusaro JR; Boué DR; Holloway MP; Altura RA
    Blood; 2007 Feb; 109(4):1479-89. PubMed ID: 17038538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.
    Malcles MH; Wang HW; Koumi A; Tsai YH; Yu M; Godfrey A; Boshoff C
    Br J Cancer; 2007 Jun; 96(11):1659-66. PubMed ID: 17505517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3.
    You RI; Chen MC; Wang HW; Chou YC; Lin CH; Hsieh SL
    Cancer Res; 2006 Mar; 66(6):3051-61. PubMed ID: 16540654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential subcellular localization of functionally divergent survivin splice variants.
    Mahotka C; Liebmann J; Wenzel M; Suschek CV; Schmitt M; Gabbert HE; Gerharz CD
    Cell Death Differ; 2002 Dec; 9(12):1334-42. PubMed ID: 12478470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
    Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
    Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
    Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing skin flap survival by a cell-permeable wild-type survivin.
    Shu MG; Guo XT; Zhen HN; Han Y; Chen FL; Li LW; Guo SZ
    Med Hypotheses; 2007; 69(4):888-91. PubMed ID: 17376603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
    Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
    Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
    Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
    Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin study: an update of "what is the next wave"?
    Li F; Ling X
    J Cell Physiol; 2006 Sep; 208(3):476-86. PubMed ID: 16557517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
    Mahotka C; Wenzel M; Springer E; Gabbert HE; Gerharz CD
    Cancer Res; 1999 Dec; 59(24):6097-102. PubMed ID: 10626797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
    Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation.
    Song Z; Wu M
    Oncogene; 2005 Apr; 24(16):2723-34. PubMed ID: 15735764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
    Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
    Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of survivin and its splice variants in tumorigenesis.
    Li F
    Br J Cancer; 2005 Jan; 92(2):212-6. PubMed ID: 15611788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.